BridgeMD
New treatment option for Pulmonary Hypertension
Official title A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
ClinicalTrials.gov ID: NCT07073820
What this study is testing
What is PF-07868489?
PF-07868489 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for pulmonary hypertension.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is high blood pressure in the arteries that carry blood from the heart to the lungs.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- This study is seeking participants who are:
- aged 18 years or older at screening of the previous study and completed the required treatment duration with PF-07868469 and other assessments at the...
- willing and able to abide with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures.
- do not have worsening or hospitalization for worsening PAH during the qualifying study.
- not on placement for a surgery to replace any tissue or part of the body (transplant), and planned surgery for PAH.
See the full eligibility criteria
- This study is seeking participants who are:
- aged 18 years or older at screening of the previous study and completed the required treatment duration with PF-07868469 and other assessments at the end of that study.
- willing and able to abide with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures.
- do not have worsening or hospitalization for worsening PAH during the qualifying study.
- not on placement for a surgery to replace any tissue or part of the body (transplant), and planned surgery for PAH.
- do not have an ongoing major health issue in the qualifying study, which in the opinion of the study doctor could make the participant not qualify for this study.
- not suffering from or in the past have suffered from hepato-pulmonary syndrome (liver-related lung problem).
- not currently prescribed or taking medicines called as GLP-1 agonist.
The study team makes the final eligibility decision.
Where it's taking place
- Sacramento, California, United States
- San Francisco, California, United States
- Aurora, Colorado, United States
- Louisville, Kentucky, United States
- New York, New York, United States
- Chapel Hill, North Carolina, United States
- Providence, Rhode Island, United States
- Camperdown, New South Wales, Australia
- Auchenflower, Queensland, Australia
- Brussels, Belgium
- Leuven, Belgium
- London, Ontario, Canada
- Guangzhou, Guangdong, China
- Changsha, Hunan, China
- Nanjing, Jiangsu, China
- Shanghai, Shanghai Municipality, China
- Prague, Czechia
- Brest, Finistère, France
- Saint-Priest-en-Jarez, France
- Heidelberg, Baden-Wurttemberg, Germany
+ 19 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sacramento, California, United States; San Francisco, California, United States; Aurora, Colorado, United States; Louisville, Kentucky, United States; New York, New York, United States; Chapel Hill, North Carolina, United States and 33 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.